AlfathanO.: Instillation of superficial bladder cancer with mitomycine C and doxorubicins J. Urol., 135; 275 (1986).
2.
DeKernionJ., Huang MyB., LindnerA., SmithR.B., KaufmanJ.J.: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J. Urol., 133; 598–601 (1985).
3.
GrupsJ.W., FrohmulerHG.E., AckermannR.: Immunological findings in patients with superficial bladder cancer during human alpha 2 interferon treatment. Urol. Intern. 40; 301–306 (1985).
4.
HeronJ., HorklandM., BergK.: Native human interferon alpha species assessed for immunoregulation properties. J. Interf. Res., 9; 231 (1983).
5.
MobleyW.C.: Use of intravesical cisplatin and mitomycine C for recurrent transitional cell carcinoma of bladder refractory to thiotepa. Urology, 27; 335–339 (1986).
6.
TortiF.M.: Alpha 2 interferon in the treatment of superficial bladder cancer. J. Interf. Res., 12; 3 (1986).
